ID BT-474 Clone 5 AC CVCL_AQ07 SY BT474 clone 5 DR ATCC; CRL-3247 DR cancercelllines; CVCL_AQ07 DR Wikidata; Q54798462 RX PubMed=14750129; CC Population: Caucasian. CC Selected for resistance to: DrugBank; DB00072; Trastuzumab (Herceptin). CC Sequence variation: Gene fusion; HGNC; HGNC:24618; AHCTF1 + HGNC; HGNC:736; NAAA; Name(s)=AHCTF1-NAAA (from parent cell line). CC Sequence variation: Gene fusion; HGNC; HGNC:16173; DOK5 + HGNC; HGNC:17579; STARD3; Name(s)=STARD3-DOK5 (from parent cell line). CC Sequence variation: Gene fusion; HGNC; HGNC:13178; IKZF3 + HGNC; HGNC:12649; VAPB; Name(s)=VAPB-IKZF3 (from parent cell line). CC Sequence variation: Gene fusion; HGNC; HGNC:16651; MRPL45 + HGNC; HGNC:16181; TRPC4AP; Name(s)=TRPC4AP-MRPL45 (from parent cell line). CC Sequence variation: Gene fusion; HGNC; HGNC:7609; MYO9B + HGNC; HGNC:9764; RAB22A; Name(s)=RAB22A-MYO9B (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser3094Ter (c.9281C>A); ClinVar=VCV000188440; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:11621; HNF1A; Simple; p.Gln495Ter (c.1483C>T); ClinVar=VCV000586785; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.His61Gln (c.183C>G); Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Asn (c.333G>C); ClinVar=VCV000376483; Zygosity=Heterozygous (from parent cell line). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Homozygous (from parent cell line). CC Derived from site: In situ; Breast; UBERON=UBERON_0000310. DI NCIt; C4194; Invasive breast carcinoma of no special type OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_0179 ! BT-474 SX Female AG 60Y CA Cancer cell line DT Created: 02-05-16; Last updated: 10-04-25; Version: 16 // RX PubMed=14750129; DOI=10.1002/cyto.a.10095; RA Kute, Timothy E. RA Lack, Christopher M. RA Willingham, Mark C. RA Bishwokama, Bimjhana RA Williams, Holly RA Barrett, Kathy RA Mitchell, Tanita RA Vaughn, James P. RT "Development of Herceptin resistance in breast cancer cells."; RL Cytometry A 57:86-93(2004). //